OPKO HEALTH INC. - CO
1.4900
26-11月-24 10:25:31
15 分の遅延
株式
-0.1300
-8.02%
本日の幅
1.4900 - 1.6050
ISIN
N/A
ソース
NASDAQ
-
OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
20 7 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics
12 7 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference
08 7 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx
22 6 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics
21 6 2021 08:03:07 提供 Nasdaq GlobeNewswire
-
OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland
17 6 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
OPKO Health to Participate in the Jefferies Virtual Healthcare Conference
27 5 2021 08:30:01 提供 Nasdaq GlobeNewswire
-
OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor
24 5 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders
07 5 2021 13:33:56 提供 Nasdaq GlobeNewswire
-
OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021
22 4 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
18 2 2021 16:05:01 提供 Nasdaq GlobeNewswire
-
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021
03 2 2021 09:01:22 提供 Nasdaq GlobeNewswire
-
28 1 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
05 1 2021 08:00:01 提供 Nasdaq GlobeNewswire